Assessment of a Single Quadrupole Mass Spectrometer Combined with an Atmospheric Solids Analysis Probe for the On-Site Identification of Amnesty Bin Drugs.
Anca Frinculescu, Benjamin Mercer, Trevor Shine, John Ramsey, Lewis Couchman, David Douce, Nunzianda Frascione, Vincenzo Abbate
Journal of the American Society for Mass Spectrometry July 3, 2024 DOI: 10.1021/jasms.4c00064 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Method development and validation study Qualitative Peer reviewed |
|---|---|
| Sample size | 366 |
| Population | Drug samples seized at summer festivals in the U.K. (on-site N = 279; off-site N = 87) |
| Key points | The ASAP-MS method correctly identified drugs in 93% of on-site samples (N = 279) and 92.5% of off-site samples (N = 87), with results confirmed by GC-MS. Partly correct results missed some low-intensity active ingredients (N-ethylpentylone, MDMA) and cutting agents (caffeine, paracetamol, benzocaine) or falsely detected them; incorrect results were mainly due to library coverage. The authors conclude the instrument can complement spectroscopic techniques for on- and off-site qualitative drug analysis. |
Abstract
The surging number of people who abuse drugs has a great impact on healthcare and law enforcement systems. Amnesty bin drug analysis helps monitor the "street drug market" and tailor the harm reduction advice. Therefore, rapid and accurate drug analysis methods are crucial for on-site work. An analytical method for the rapid identification of five commonly detected drugs ((3,4-methylenedioxymethamphetamine (MDMA), cocaine, ketamine, 4-bromo-2,5-dimethoxyphenethylamine, and chloromethcathinone)) at various summer festivals in the U.K. was developed and validated employing a single quadrupole mass spectrometer combined with an atmospheric pressure solids analysis probe (ASAP-MS). The results were confirmed on a benchtop gas chromatography-mass spectrometry instrument and included all samples that challenged the conventional spectroscopic techniques routinely employed on-site. Although the selectivity/specificity step of the validation assessment of the MS system proved a challenge, it still produced 93% (N = 279) and 92.5% (N = 87) correct results when tested on- and off-site, respectively. A few "partly correct" results showed some discrepancies between the results, with the MS-only unit missing some low intensity active ingredients (N-ethylpentylone, MDMA) and cutting agents (caffeine, paracetamol, and benzocaine) or detecting some when not present. The incorrect results were mainly based on library coverage. The study proved that the ASAP-MS instrument can successfully complement the spectroscopic techniques used for qualitative drug analysis on- and off-site. Although the validation testing highlighted some areas for improvement concerning selectivity/specificity for structurally similar compounds, this method has the potential to be used in trend monitoring and harm reduction.
Citations in the library
Cites 6
- Effects of MDMA, MDA and MDEA on blood pressure, heart rate, locomotor activity and body temperature in the rat involveα‐adrenoceptors British Journal of Pharmacology February 20, 2006
- Production Options for Psilocybin: Making of the Magic Chemistry - A European Journal July 16, 2018
- Variability in content and dissolution profiles of MDMA tablets collected in the UK between 2001 and 2018 – A potential risk to users? Drug Testing and Analysis April 22, 2019
- Tusi: a new ketamine concoction complicating the drug landscape. The American Journal of Drug and Alcohol Abuse September 3, 2023
- Drug use, harm-reduction practices and attitudes toward the utilisation of drug safety testing services in an Irish cohort of festival-goers. Irish Journal of Medical Science August 2022
and 1 more in the library